Keyphrases
Systemic Lupus Erythematosus
100%
Disease Activity
78%
Psoriatic Arthritis
65%
Arthritis Patients
65%
Knee Osteoarthritis
65%
Osteoarthritis
63%
Body Mass Index
60%
Active Compounds
52%
Indonesia
48%
Axial Spondyloarthritis (AxSpA)
43%
Calcidiol
43%
Antigen-induced Arthritis
43%
Collagen-induced Arthritis
43%
Hyperbaric Oxygen
43%
Green Tea
43%
Serum Interleukins
43%
Interleukin-17 (IL-17)
42%
Bone Mineral Density
37%
Rheumatoid Arthritis
34%
Knee Pain
34%
Sodium Intake
34%
Interleukin-23 (IL-23)
34%
DAPSA
33%
Interferon-α (IFN-α)
32%
Single nucleotide Polymorphism
30%
Risk Factors
30%
Hypoxia-inducible factor-1α (HIF-1α)
29%
Sodium
29%
Spondyloarthritis
28%
Expression Level
27%
C-reactive Protein
26%
Systemic Lupus Erythematosus Patient
25%
Psoriasis
24%
Hyperbaric Oxygen Therapy
23%
C-reactive Protein Level
23%
Methylprednisolone
22%
Radiographic Damage
21%
Acute Appendicitis
21%
Inhibition Pathway
21%
25-hydroxyvitamin D (25OHD)
21%
Quercetin-3-O-rhamnoside
21%
Symptomatic Osteoarthritis
21%
ERAP1
21%
Metabolic Syndrome
21%
Lupus-prone Mice
21%
Endoplasmic Reticulum Aminopeptidase
21%
Serum miR-21
21%
T Helper 17 (Th17)
21%
Caspase-1
21%
Pain Activity
21%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
87%
Disease Activity
56%
Arthritis
52%
Spondylarthritis
46%
Psoriatic Arthritis
43%
Hypoxia Inducible Factor 1
43%
Collagen-Induced Arthritis
43%
Calcifediol
43%
Diseases
32%
Antioxidant
29%
Cross-Sectional Study
27%
Quercetin
27%
Interleukin 6
25%
Methylprednisolone
22%
Acute Appendicitis
21%
Interleukin 23
21%
Sclerostin
21%
Psoriasis
21%
Preeclampsia
21%
Metabolic Syndrome X
21%
Camellia Sinensis
21%
Pyroptosis
21%
Bryophyllum pinnatum
21%
Bond Energy
21%
microRNA 21
21%
Acetic Acid Ethyl Ester
21%
Osteoclast Differentiation Factor
21%
Lupus Erythematosus Nephritis
21%
Anti-Inflammatory Drug
21%
Inflammatory Arthritis
21%
Rheumatoid Arthritis
21%
Immunomodulating Agent
14%
Biological Marker
12%
Placebo
11%
Mammalian Target of Rapamycin Inhibitor
10%
Psoriasis Vulgaris
10%
Epigallocatechin
10%
Chlordane
10%
Interferon
10%
Catechin
10%
Treatment Group
10%
Enzyme-Linked Immunosorbent Assay
8%
Pathophysiology
8%
Autoimmune Disease
8%
Inflammation
8%
Ankylosing Spondylitis
7%
Infection
7%
Theaflavin
7%
Anti-Inflammation
7%
Biological Activity
7%
Medicine and Dentistry
Systemic Lupus Erythematosus
65%
Inflammatory Arthritis
32%
Rheumatoid Arthritis
32%
Knee Joint
25%
Prevalence
23%
Methylprednisolone
22%
Mammalian Target of Rapamycin
21%
Lupus Erythematosus
21%
Quercetin
21%
Pre-Eclampsia
21%
Arthralgia
21%
Metabolic Syndrome
21%
Periodontitis
21%
Sodium Intake
21%
Acute Appendicitis
21%
Cross Sectional Study
21%
Spondylarthritis
21%
Psoriasis
21%
Lupus Nephritis
21%
Osteoarthritis
21%
Hyperbaric Medicine
21%
Collagen-Induced Arthritis
21%
Hypoxia Inducible Factor 1
21%
Body Mass Index
12%
AMP-Activated Protein Kinase
10%
Secretion (Process)
10%
Psoriasis Vulgaris
10%
Diseases
10%
Placebo
8%
Fetus Lung Maturation
8%
Anti-Inflammatory Drug
8%
Interleukin 6
8%
Pathophysiology
8%
Autoimmune Disease
8%
Ankylosing Spondylitis
7%
Infection
7%
Interleukin 17
7%
Autophagy
7%
Target Protein
7%
Paw
7%
Treatment Group
7%
C Reactive Protein
6%
Outpatient
5%
Observational Study
5%
Methotrexate
5%
Erythroderma
5%
Overlap Syndrome
5%
Photosensitivity
5%
Dermatosis
5%
Population
5%